Stem Cell Research (Jan 2022)

Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation

  • Yiming Dong,
  • Xiaowei Li,
  • Wanrong Fu,
  • Xiaoxu Tian,
  • Guangli Guo,
  • Ying Peng,
  • Yafei Zhai,
  • Jiangtao Zhao,
  • Zhongren Ding,
  • Xiaoyan Zhao,
  • Jianzeng Dong

DOI
https://doi.org/10.1016/j.scr.2021.102622
Journal volume & issue
Vol. 58
p. 102622

Abstract

Read online

A 25-years-old hypertrophic cardiomyopathy male patient donated his peripheral blood mononuclear cells (PBMCs) with heterozygote mutation in theTNNT2 gene. We generated induced pluripotent stem cell (iPSC) with normal karyotypic and expressing NANOG, Lin28, GDF3 and DNMT3. The iPSC line has demonstrated pluripotency by differentiating into three germ layers in vitro. The ZZUNEUi021-A would serve as an in vitro model for loss of TNNT2 function.